Greece stands at a pivotal moment to strengthen its position in the field of clinical trials and transform clinical research into a cornerstone of development for the National Healthcare System (ESY), the scientific community—and, most importantly, patients themselves. In recent years, meaningful progress has been made in this direction. Yet the real challenge now lies in building a stable, well-organized, and internationally competitive clinical research ecosystem.
A Leading Regional Initiative
The 1st Health Region of Attica aims to play a pioneering role in this national effort. It is advancing initiatives that enhance operational capacity, transparency, and coordination across its hospitals in clinical research. Central to this strategy is the implementation of the Ministry of Health’s decision mandating the establishment of autonomous clinical trial offices and dedicated units within ESY hospitals.
The 1st Health Region has already begun the phased rollout of independent clinical trial offices across its network of hospitals. The goal is to create more agile, specialized, and efficient administrative structures capable of fully supporting research activities—from protocol review and ethics approval to contract management and monitoring.
Investing in People and Expertise
Parallel to structural reforms, the 1st Health Region is systematically investing in training and capacity-building for staff involved in clinical trials. Training and continuing education programs have already been launched for both administrative and scientific personnel—aimed at fostering shared understanding, deepening expertise, and ensuring operational readiness at all levels. Strengthening technical know-how is essential for hospitals to meet the growing demands of modern clinical research.
Standardized Processes for Greater Efficiency
Equally important is the Region’s plan to introduce standardized procedures and common operational frameworks across its hospitals. Uniform processes, aligned timelines, and harmonized administrative steps can significantly reduce delays, improve transparency, and foster a more predictable and trustworthy environment for sponsors, pharmaceutical companies, and research organizations.
This effort is reinforced by a recent regulatory update setting clear time limits for signing clinical trial and research project contracts—a targeted response to one of Greece’s long-standing bottlenecks: excessive administrative delays. Predictability and speed in procedural execution are now key competitiveness indicators on the global stage.
Yet expanding clinical trial activity depends not only on institutional streamlining. It also requires robust operational support for hospitals—including specialized staff such as study coordinators, as well as administrative, financial, legal, and digital infrastructure to track contracts, budgets, and milestones effectively.